论文部分内容阅读
西欧国家60岁以上者慢性淋巴性白血病(CLL)的年发病率为20/10万。一般认为进展期的CLL病人应立即化疗。法国CLL协作组通过对比研究发现氟达拉滨与CAP(环磷酰胺、阿霉素、强的
The annual incidence of chronic lymphocytic leukemia (CLL) in Western European countries over 60 years old is 20/100,000. It is generally believed that advanced CLL patients should be treated immediately. The French CLL Collaboration Group found that Fludarabine and CAP (cyclophosphamide, doxorubicin, and strong